Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8442552 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
Despite clear differences to the United States in terms of tobacco use, the increase in OPSCC incidence in a European population was also mainly attributed to HPV, and the HPV status significantly affected prognosis. For clinical trial design it is important to consider the large group of smokers within HPV-induced OPSCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
I. Tinhofer, K. Jöhrens, U. Keilholz, A. Kaufmann, A. Lehmann, W. Weichert, A. Stenzinger, C. Stromberger, K. Klinghammer, E.-T. Becker, S. Dommerich, K. Stölzel, V.M. Hofmann, B. Hildebrandt, L. Moser, J. Ervens, A. Böttcher, A. Albers, J.D. Raguse,